Internal Medicine, Nephrology · Bloomfield, CT
NPI
1710927892
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
701 Cottage Grove Rd, Suite A210
Bloomfield, CT, 06002
Phone (860) 769-9866
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
1,169 services
Medicare patients, 2024
382
Average age 77
Drug cost, 2024
$503K
2,002 prescriptions
Company payments, 2025
$83K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ari B Geller was code 99232 (hospital e&m - subsequent), 272 times for 115 patients. In total Ari B Geller billed 1,169 services in 21 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 272 | 115 | $63.40 | $17K |
| 99214 Office E&M - Established | Office | 200 | 131 | $90.23 | $18K |
| 90960 ESRD Related Services (not dialysis) | Facility | 123 | 24 | $283.68 | $35K |
| 90935 Hemodialysis | Facility | 84 | 41 | $55.90 | $4,696 |
| 90961 ESRD Related Services (not dialysis) | Facility | 67 | 22 | $238.49 | $16K |
| 99213 Office E&M - Established | Office | 63 | 61 | $69.32 | $4,367 |
| 90945 Peritoneal Dialysis | Facility | 47 | 16 | $69.55 | $3,269 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 38 | $94.29 | $4,243 |
| 90960 ESRD Related Services (not dialysis) | Office | 35 | 15 | $282.63 | $9,892 |
| 99222 Hospital E&M - Initial | Facility | 33 | 31 | $104.16 | $3,437 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 28 | $40.19 | $1,166 |
| 99223 Hospital E&M - Initial | Facility | 26 | 26 | $135.06 | $3,512 |
| 90961 ESRD Related Services (not dialysis) | Office | 23 | 11 | $239.37 | $5,506 |
| 99204 Office E&M - New | Office | 21 | 21 | $122.94 | $2,582 |
By year: 2022 $168K for 1,465 services; 2023 $144K for 1,236 services; 2024 $145K for 1,169 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ari B Geller prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 171 prescriptions and refills. In total Ari B Geller wrote 2,002 Medicare prescriptions that cost $503K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 171 | 204 | 30 | $115K |
| Amlodipine Besylate Generic | 171 | 337 | 49 | $1,015 |
| Jardiance Empagliflozin | 159 | 203 | 30 | $120K |
| Torsemide Generic | 137 | 259 | 39 | $2,912 |
| Lisinopril Generic | 98 | 211 | 26 | $417 |
| Clinolipid Fat Emulsion/Olive/Soy/Phospho | 96 | 96 | Under 11 | $39K |
| Losartan Potassium Generic | 81 | 204 | 24 | $454 |
| Calcitriol Generic | 81 | 167 | 26 | $1,588 |
| Valsartan Generic | 69 | 171 | 21 | $608 |
| Sevelamer Carbonate Generic | 67 | 125 | 24 | $11K |
| Kerendia Finerenone | 49 | 79 | Under 11 | $51K |
| Prosol Parenteral Amino Acid 20% No.1 | 48 | 48 | Under 11 | $7,785 |
| Furosemide Generic | 48 | 112 | 16 | $127 |
| Spironolactone Generic | 45 | 91 | 13 | $409 |
| Doxazosin Mesylate Generic | 44 | 92 | 11 | $407 |
Brand drugs: 656 claims; generic drugs: 1,346 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ari B Geller $83K ($83K in general payments such as food, travel and fees) from 16 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $42K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 32 | $42K |
| Akebia Therapeutics Inc AKBA | 39 | $24K |
| Lilly USA, LLC LLY | 8 | $8,040 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $4,600 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $3,727 |
| Medtronic, Inc. MDT | 2 | $214 |
| Travere Therapeutics, Inc. TVTX | 4 | $147 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 3 | $74.87 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $62.14 |
| Novo Nordisk Inc NVO | 2 | $39.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.